Program

Our Scientific Program

Program Schedule

  • Day 1
  • Day 2
  • Day 3

10 May 2026 – Day 1

Research Integration and Global Innovation

Focuses on advancing scientific research and global collaboration in Fragile X and related neurogenetic conditions. The program highlights recent discoveries in molecular genetics, emerging therapeutic approaches, and international research initiatives, bringing together researchers, clinicians, and scientists to exchange knowledge and strengthen global partnerships.

Time

Session

8:00 AM

Registration & Coffee Break

9:00 AM

Welcome Remarks

9:30 AM

Keynote Speakers:

1.    “Fragile X Spectrum Disorders and new Treatments” – Dr. Randi Hagerman, MD, FAAP

2.    “Molecular/ Genetic Insights: Fragile X Premutation- Associated Conditions (FXPAC)” – Dr. Paul Hagerman, MD, PhD

3.    “Molecular Biomarkers of FXTAS – Dr. Flora Tassone, PhD

4.    Genetic Research in Africa (GEN-IMPACT vision) Dr. Mohamed Salama, PhD

11:30 AM

“Navigating Fragile X: A Genetic Counselor’s Perspective on Inheritance, Cascade Testing, and the Multigenerational Family Impacts” – Susan Howell, MS, CGC, MBA

12:00 PM

Lunch

1:00 PM

20-minute talks (To be posted soon)

2:00 – 3:00 PM

Poster Session

11 May 2026 – Day 2

Education & Public Health Strategies

Emphasizes education, advocacy, and public health approaches for Fragile X and neurodevelopmental conditions. Sessions explore regional perspectives, patient advocacy, and strategies to improve access to services and support systems, supporting translation of research into effective public health and educational practice.

Time

Session

8:00 AM

Networking & Coffee Break

9:00 AM

Keynote Speakers:

Neurodevelopmental Conditions in Egypt – Dr. Nagwa Abdel Meguid, MD, PhD

9:30 AM

Phenotypes and potential therapies in Fragile X syndrome and Autism- Prof. Flora Tassone, PhD

10:00 AM

Using Patient Advocacy to bridge the gap between services provided and services desired – Robert Miller – Director of Clinic & International Relations

National FX Foundation

10:30 AM

Break

11:00 AM

20-minute talks (To be posted soon)

12:00 PM

Lunch

1:00 – 2:00 PM

Poster Session

2:15 – 3:00 pm

Closing Remarks

12 May 2026 – Day 3

Clinics Day

Dedicated to clinical practice and direct patient care. Participants engage in specialized consultations and genetic counseling sessions focused on diagnosis, management, and family-centered care, supporting practical application through individualized clinical discussions and expert guidance.

Time

Session

9:00 AM – 1:00 PM

Consultations: Dr. Nagwa Abdel Megid, Dr. Randi & Robby Miller

Genetic Counselor: Susan Howell

 

Keynote Speaker

Keynote Speaker

Are You Ready?

Join a global community shaping the future of neurodevelopmental research, care, and advocacy.

Pharmacist, Scientist & Higher-Education Leader

Dr. Reem Olaby

Dr. Reem Olaby is a pharmacist, scientist, and higher-education leader actively engaged in curriculum reform, faculty development, and academic governance.

Her scholarly work focuses on the genetic, epigenetic, and proteomic underpinnings of neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), Fragile X syndrome (FXS), and Fragile X–associated tremor/ataxia syndrome (FXTAS).

She is dedicated to translating molecular research into impactful education strategies, clinical training initiatives, and interdisciplinary collaboration.

Research Focus : 

Neurodevelopmental Disorders

0 +

Professional Speakers

0 +

Sponsers & Partners